Key result
10-Gingerol alleviates arsenic trioxide-induced cardiotoxicity via PI3K/AKT activation in preclinical models.
Why the study?
Arsenic trioxide causes severe cardiotoxicity that limits its clinical use, but the cardioprotective effects and mechanisms of 10-gingerol against arsenic trioxide-induced heart injury have not been fully elucidated.
Does 10-Gingerol alleviate arsenic trioxide-induced cardiotoxicity in preclinical models?
Does 10-Gingerol alleviate arsenic trioxide-induced cardiotoxicity in preclinical models?
10-Gingerol protects against arsenic trioxide-induced cardiotoxicity in preclinical models by activating the PI3K/AKT pathway, reducing oxidative stress, inflammation, and apoptosis.
Answers are grounded in this paper and cite their sources.
Supports 10-gingerol exploration in arsenic trioxide models; hypothesis-generating and requires human trials before any clinical consideration.
Arsenic trioxide (ATO) is an effective chemotherapeutic agent but causes severe cardiotoxicity, which limits its clinical application. 10‐Gingerol (10Gin) is a major bioactive component of ginger, yet its cardioprotection and the mechanism underlying its effects against ATO‐induced heart injury (HI) have not been fully elucidated. This study integrated network pharmacology (NP) analysis, in vivo mouse models, and in vitro cell experiments to investigate the cardioprotection of 10Gin against ATO‐induced HI and its underlying mechanisms. NP analysis identified 32 overlapping therapeutic targets of 10Gin, ATO, and HI, among which the phosphoinositide 3‐kinase/protein kinase B (PI3K/AKT) pathway was the most significantly enriched cardiovascular‐related pathway. Our in vivo experimental results demonstrated that 10Gin treatment significantly ameliorated ATO‐induced histopathological injury and cardiac dysfunction in mice. Echocardiographic evaluation showed that 10Gin improved ATO‐induced systolic dysfunction, as evidenced by increased ejection fraction and fractional shortening. Specifically, 10Gin reduced serum levels of myocardial injury markers, enhanced endogenous antioxidant enzyme activities, decreased reactive oxygen species production, downregulated pro‐inflammatory cytokine mRNA expression, and inhibited cardiomyocyte apoptosis. In vitro experiments involving H9c2 cells and AC16 human cardiomyocytes showed that 10Gin enhanced cell viability, attenuated apoptosis and oxidative stress, thereby exerting cardioprotective effects. Moreover, 10Gin significantly increased the p‐PI3K/PI3K and p‐AKT/AKT ratios both in vivo and in vitro. Notably, the in vitro cardioprotection of 10Gin could be partly reversed by the PI3K inhibitor LY294002. These findings indicate that 10Gin alleviates ATO‐induced HI through antioxidant, anti‐inflammatory, and anti‐apoptotic mechanisms, which are likely mediated by PI3K/AKT activation, thereby supporting further investigation of 10Gin as a potential adjunctive candidate.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2026) studied Arsenic trioxide-induced heart injury (n=50). 10-Gingerol vs. Arsenic trioxide alone was evaluated on Cardiac dysfunction and histopathological injury (p=<0.01). 10-Gingerol significantly alleviated arsenic trioxide-induced heart injury in mice by improving cardiac function and reducing oxidative stress, inflammation, and apoptosis via PI3K/AKT pathway activation.
Synapse has enriched 10 related papers. Consider them for comparative context: